Minireviews
Copyright ©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Aug 6, 2016; 7(3): 406-411
Published online Aug 6, 2016. doi: 10.4292/wjgpt.v7.i3.406
Table 2 Risk of Prevalent neoplasia in patients with Barrett’s esophagus with epithelial change indefinite for dysplasia
Ref.Number of casesPrevalent LGD, n (%)Prevalent HGD, n (%)Prevalent adenocarcinoma n (%)Prevalent advanced neoplasia
Montgomery et al[11], 200170 (0)0 (0)1 (15)At least 1 (15)
Sonwalkar et al[9], 201041At least 1 (2.4)0 (0)At least 1 (2.4)At least 1 (2.4)
Choi et al[14], 201596At least 14 (14.5)Not knownNot knownAt least 10 (10)
Horvath et al[12], 20151077 (8.2)2 (2.35)2 (2.35)4 (4.7)
Kestens et al[15], 2015842101 (12.1)Not knownNot known16 (1.9)
Sinh et al[16], 201583Not known0 (0)0 (0)0 (0)